Natural killer cells in cancer

Seminars in Cancer Biology

Volumn 16, Issue 5, 2006, Pages 331-332

  Höglund, Petter ^a   Klein, Eva ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR NKG2D;

B LYMPHOCYTE; CANCER CELL; CANCER IMMUNIZATION; CELL INTERACTION; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; DNA DAMAGE; EDITORIAL; IMMUNOREGULATION; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; MOLECULAR MECHANICS; MOLONEY LEUKEMIA ONCOVIRUS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNOLOGY;

ANIMALS; B-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENES, MHC CLASS I; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; MICE; NEOPLASMS; T-LYMPHOCYTES;

EID: 33748154505     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2006.08.002     Document Type: Editorial

References (12)

1. Old L.J., and Stockert E. Immunogenetics of cell surface antigens of mouse leukemia. Annu Rev Genet 11 (1977) 127-160
2. Kiessling R., Klein E., and Wigzell H. Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5 (1975) 112-117
3. Kiessling R., Klein E., Pross H., and Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5 (1975) 117-121
4. Herberman R.B., Nunn M.E., and Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16 (1975) 216-229
5. Herberman R.B., Nunn M.E., Holden H.T., and Lavrin D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 16 (1975) 230-239
6. Karre K., Ljunggren H.-G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319 (1986) 675-678
7. Karlhofer F.M., Ribaudo R.K., and Yokoyama W.M. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358 (1992) 66-70
8. Moretta A., Vitale M., Bottino C., Orengo A.M., Morelli L., Augugliaro R., et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178 (1993) 597-604
9. Johansson S., Berg L., Hall H., and Höglund P. NK cells: elusive players in autoimmunity. Trends Immunol 26 (2005) 613-618
10. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
11. Klein E., Di Renzo L., and Yefenof E. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells. Mol Immunol 27 (1990) 1343-1347
12. Ljunggren H.-G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11 (1990) 237-244